IRIDEX EBITDA Margin 2010-2024 | IRIX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for IRIDEX (IRIX) over the last 10 years. The current EBITDA margin for IRIDEX as of September 30, 2024 is .
| IRIDEX EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-09-30 |
$0.05B |
$-0.01B |
-20.41% |
| 2024-06-30 |
$0.05B |
$-0.01B |
-18.00% |
| 2024-03-31 |
$0.05B |
$-0.01B |
-18.00% |
| 2023-12-31 |
$0.05B |
$-0.01B |
-15.38% |
| 2023-09-30 |
$0.06B |
$-0.01B |
-10.91% |
| 2023-06-30 |
$0.06B |
$-0.01B |
-12.28% |
| 2023-03-31 |
$0.06B |
$-0.01B |
-12.07% |
| 2022-12-31 |
$0.06B |
$-0.01B |
-12.28% |
| 2022-09-30 |
$0.06B |
$-0.01B |
-14.04% |
| 2022-06-30 |
$0.06B |
$-0.01B |
-14.55% |
| 2022-03-31 |
$0.05B |
$-0.01B |
-12.96% |
| 2021-12-31 |
$0.05B |
$-0.01B |
-13.21% |
| 2021-09-30 |
$0.05B |
$-0.01B |
-10.00% |
| 2021-06-30 |
$0.05B |
$-0.01B |
-10.87% |
| 2021-03-31 |
$0.04B |
$-0.01B |
-17.95% |
| 2020-12-31 |
$0.04B |
$-0.01B |
-19.44% |
| 2020-09-30 |
$0.04B |
$-0.01B |
-22.22% |
| 2020-06-30 |
$0.04B |
$-0.01B |
-21.05% |
| 2020-03-31 |
$0.04B |
$-0.01B |
-16.67% |
| 2019-12-31 |
$0.04B |
$-0.01B |
-18.18% |
| 2019-09-30 |
$0.04B |
$-0.01B |
-23.26% |
| 2019-06-30 |
$0.04B |
$-0.01B |
-25.58% |
| 2019-03-31 |
$0.04B |
$-0.01B |
-27.91% |
| 2018-12-31 |
$0.04B |
$-0.01B |
-28.57% |
| 2018-09-30 |
$0.04B |
$-0.01B |
-34.15% |
| 2018-06-30 |
$0.04B |
$-0.01B |
-34.15% |
| 2018-03-31 |
$0.04B |
$-0.01B |
-34.15% |
| 2017-12-31 |
$0.04B |
$-0.01B |
-31.71% |
| 2017-09-30 |
$0.04B |
$-0.01B |
-20.45% |
| 2017-06-30 |
$0.04B |
$-0.01B |
-16.28% |
| 2017-03-31 |
$0.05B |
$-0.00B |
-8.89% |
| 2016-12-31 |
$0.05B |
$-0.00B |
-4.26% |
| 2016-09-30 |
$0.05B |
0 |
0.00% |
| 2016-06-30 |
$0.05B |
$0.00B |
2.17% |
| 2016-03-31 |
$0.04B |
0 |
0.00% |
| 2015-12-31 |
$0.04B |
$0.00B |
2.38% |
| 2015-09-30 |
$0.04B |
$0.00B |
2.38% |
| 2015-06-30 |
$0.04B |
$0.00B |
4.76% |
| 2015-03-31 |
$0.04B |
$0.00B |
6.82% |
| 2014-12-31 |
$0.04B |
$0.00B |
6.98% |
| 2014-09-30 |
$0.04B |
$0.00B |
7.14% |
| 2014-06-30 |
$0.04B |
$0.00B |
7.14% |
| 2014-03-31 |
$0.04B |
$0.00B |
10.00% |
| 2013-12-31 |
$0.04B |
$0.00B |
10.26% |
| 2013-09-30 |
$0.04B |
$0.00B |
8.11% |
| 2013-06-30 |
$0.04B |
$0.00B |
5.71% |
| 2013-03-31 |
$0.03B |
$0.00B |
2.94% |
| 2012-12-31 |
$0.03B |
0 |
0.00% |
| 2012-09-30 |
$0.03B |
$0.00B |
3.03% |
| 2012-06-30 |
$0.03B |
$0.00B |
3.03% |
| 2012-03-31 |
$0.03B |
$0.00B |
3.03% |
| 2011-12-31 |
$0.03B |
$0.00B |
3.03% |
| 2011-09-30 |
$0.03B |
$-0.00B |
-4.00% |
| 2011-06-30 |
$0.03B |
0 |
0.00% |
| 2011-03-31 |
$0.03B |
0 |
0.00% |
| 2010-12-31 |
$0.03B |
$0.00B |
3.03% |
| 2010-09-30 |
$0.03B |
$0.00B |
3.23% |
| 2010-06-30 |
$0.03B |
$0.00B |
3.33% |
| 2010-03-31 |
$0.03B |
$0.00B |
6.45% |
| 2009-12-31 |
$0.03B |
$0.00B |
6.45% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.028B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
